Rasmussen N, Tribukait B, Thomsen J, Holm L E, Tos M
Acta Otolaryngol Suppl. 1984;406:278-81. doi: 10.3109/00016488309123050.
Based on in vitro detection of cell-mediated immunity against human acoustic neuroma extract, a malignant potential of acoustic neuromas could be surmised, as malignant DNA patterns have been demonstrated in benign pituitary tumours. Flow-cytofluorometric characterization of the DNA content in 10 human acoustic neuromas, however, only revealed diploid cell lines and normal distributions of cells in different cell cycle phases. All acoustic neuromas were histopathology benign. The percentage of cells in S-phase (range: 1.8-8.3%, median: 3.6%) reflected a slow growth rate correlated neither to age, size of tumour, nor length of case history at time of surgery. These findings may in part be due to the analytical variation in the determinations of the S-phases. The investigation has not offered any explanation for the observed cell-mediated immunity against acoustic neuromas, and confirms that acoustic neuromas are benign tuours.
基于对人听神经瘤提取物细胞介导免疫的体外检测,鉴于在良性垂体瘤中已证实存在恶性DNA模式,故可推测听神经瘤具有恶性潜能。然而,对10例人听神经瘤的DNA含量进行流式细胞荧光分析,结果仅显示二倍体细胞系以及不同细胞周期阶段细胞的正常分布。所有听神经瘤在组织病理学上均为良性。处于S期的细胞百分比(范围:1.8 - 8.3%,中位数:3.6%)反映出其生长缓慢,且与年龄、肿瘤大小或手术时的病史长短均无关联。这些发现部分可能归因于S期测定中的分析差异。该研究尚未对所观察到的针对听神经瘤的细胞介导免疫作出任何解释,并证实听神经瘤为良性肿瘤。